The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 27, 2022

Filed:

Aug. 29, 2019
Applicant:

California Institute of Technology, Pasadena, CA (US);

Inventors:

Xiaojing Gao, Pasadena, CA (US);

Lucy S. Chong, Pasadena, CA (US);

Michael B. Elowitz, Pasadena, CA (US);

Matthew S-M Kim, San Francisco, CA (US);

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/00 (2006.01); A61K 45/06 (2006.01); C07K 16/10 (2006.01); A61K 48/00 (2006.01); C12N 15/00 (2006.01); C12N 15/86 (2006.01); C12N 15/62 (2006.01); C07K 16/18 (2006.01); C07K 14/005 (2006.01); C12N 9/50 (2006.01); C12N 7/00 (2006.01);
U.S. Cl.
CPC ...
C12N 15/86 (2013.01); C07K 14/005 (2013.01); C07K 16/18 (2013.01); C12N 7/00 (2013.01); C12N 9/506 (2013.01); C12N 15/62 (2013.01); C12Y 304/21098 (2013.01); C07K 2317/569 (2013.01); C07K 2317/622 (2013.01); C07K 2319/30 (2013.01); C07K 2319/50 (2013.01); C12N 2740/11045 (2013.01); C12N 2760/20143 (2013.01); C12N 2810/6054 (2013.01); C12N 2820/002 (2013.01); C12N 2820/007 (2013.01);
Abstract

Disclosed herein include methods, compositions, and systems suitable for use in delivering a polynucleotide to a target cell of a subject in need thereof. In some embodiments, a viral vector comprises a polynucleotide encoding nucleoprotein (N), phosphoprotein (P), matrix protein (M), RNA-dependent RNA polymerase (L), and one or more transgenes. The viral vector can comprise one or more of a conditionally stable fusion protein, a protease fusion protein, a degron fusion protein, and/or a glycoprotein derived of another species than the viral vector polynucleotide to enable control of viral vector transduction and/or replication.


Find Patent Forward Citations

Loading…